Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.030
-0.020 (-1.90%)
May 29, 2026, 4:00 PM EDT - Market closed
Lucid Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.13 | 4.71 | 4.35 | 2.43 | 0.38 | 0.5 | |
Revenue Growth (YoY) | 23.03% | 8.28% | 79.00% | 544.03% | -24.60% | - |
Cost of Revenue | 6.75 | 6.67 | 7.1 | 5.98 | 3.61 | 0.59 |
Gross Profit | -1.61 | -1.96 | -2.75 | -3.55 | -3.24 | -0.09 |
Selling, General & Admin | 41.78 | 41.58 | 36.62 | 35.66 | 40.11 | 18.04 |
Depreciation & Amortization Expenses | 0.42 | 0.42 | 0.69 | 2.02 | 1.65 | - |
Research & Development | 5.46 | 5.68 | 5.99 | 7.25 | 11.26 | 9.3 |
Total Operating Expenses | 47.66 | 47.68 | 43.3 | 44.93 | 53.01 | 27.33 |
Operating Income | -49.27 | -49.64 | -46.05 | -48.48 | -56.25 | -27.42 |
Interest Income | 0.39 | 0.39 | 0.32 | 0.42 | 0.09 | - |
Interest Expense | -0.02 | -0.02 | -0.03 | -0.42 | -0.01 | -0.66 |
Other Non-Operating Income (Expense) | 3.89 | -8.73 | 0.23 | -4.19 | - | - |
Total Non-Operating Income (Expense) | 4.26 | -8.37 | 0.52 | -4.18 | 0.08 | -0.66 |
Pretax Income | -45.01 | -58.01 | -45.53 | -52.67 | -56.17 | -28.08 |
Net Income | -58.18 | -70.57 | -53.03 | -52.67 | -56.17 | -28.08 |
Net Income Attributable to Preferred Dividends | 13.17 | 12.56 | 7.5 | - | - | - |
Net Income to Common | -58.18 | -70.57 | -53.03 | -52.67 | -56.17 | -28.08 |
Shares Outstanding (Basic) | 120 | 102 | 51 | 50 | 63 | 27 |
Shares Outstanding (Diluted) | 120 | 102 | 51 | 50 | 63 | 27 |
Shares Change (YoY) | 111.88% | 101.81% | 0.81% | -19.84% | 133.33% | 31.80% |
EPS (Basic) | -0.47 | -0.69 | -1.05 | -1.05 | -0.90 | -1.05 |
EPS (Diluted) | -0.47 | -0.69 | -1.05 | -1.05 | -0.90 | -1.05 |
Shares Outstanding | 164.88 | 131.1 | 63.07 | 50.8 | 58.35 | 50.28 |
Free Cash Flow | -46.44 | -46.68 | -44.44 | -33.04 | -30.59 | -18.53 |
Free Cash Flow Per Share | -0.39 | -0.46 | -0.88 | -0.66 | -0.49 | -0.69 |
Gross Margin | -31.38% | -41.73% | -63.35% | -146.25% | -858.62% | -17.00% |
Operating Margin | -959.64% | -1054.82% | -1059.64% | -1996.79% | -14920.70% | -5483.80% |
Profit Margin | -876.72% | -1232.68% | -1047.61% | -2169.11% | -14899.50% | -5615.60% |
FCF Margin | -904.56% | -991.97% | -1022.46% | -1360.71% | -8114.85% | -3706.00% |
EBITDA | -48.4 | -48.77 | -44.89 | -45.98 | -54.32 | -27.42 |
EBITDA Margin | -942.64% | -1036.29% | -1032.79% | -1893.86% | -14407.20% | -5483.00% |
EBIT | -49.27 | -49.64 | -46.05 | -48.48 | -56.25 | -27.42 |
EBIT Margin | -959.64% | -1054.82% | -1059.64% | -1996.79% | -14920.70% | -5483.80% |